Nosocomial urinary infection and implicated microorganisms

Authors

  • Marvin Beltrán Fundación Clínica Shaio
  • Diana Muñoz Universidad de Ciencias Aplicadas y Ambientales (UDCA)
  • Fabián Dávila Fundación Clínica Shaio

DOI:

https://doi.org/10.18041/2390-0512/biociencias.1.7837

Keywords:

Hospital infections Catheter, Related Infections Urologic, Diseases, Sonda, Length of Stay

Abstract

Introduction: The nosocomial urinary tract infections are a common complication and a major health problem due to complications and frequent recurrences. It aims to identify microorganisms involved in nosocomial urinary infections, their relationship with the use of probe and hospital stay. Materials & methods: A descriptive retrospective study. Surveillance bases restricting urinary tract infections hospital origins were reviewed; general characteristics were described and differences between the lengths of time of stay were screened by microorganism Kluskal Wallis for a significance level of 95%. Results: 167 urinary tract infections were found of hospital origin, the median age was found to be of 75; most females (58%), 34.1% associated with the use of probe; 10% died in the hospital, most came from the adult intensive care unit. The most frequently isolated microorganism was Escherichia coli (46.1%); patients contributed a median stay of 20 days. Significant differences in length of stay by microorganism isolated in catheter-associated urinary tract infection was found, the microorganism related to the greatest length of stay was Proteus mirabilis; the remaining differences were not significant. Conclusions: The most frequently isolated microorganism was Escherichia coli, Proteus mirabilis was found to be related to probe the use and length of stay, additional studies are required to determine associations between hospital stay and resistance phenotypes empirical treatment protocols available to the date, consistent microorganisms isolated.

Downloads

Download data is not yet available.

References

Iacovelli V, Gaziev G, Topazio L, Bove P, Vespasiani G, Finazzi Agrò E. Nosocomial urinary tract infections: A review. Urologia. 81(4):222-227. http://www.ncbi.nlm.nih.gov/pubmed/25451882.

Kyabaggu D, Ejobi F, Olila D. The sensitivities to first-line antibiotic therapy of the common urinary tract bacterial infections detected in urine samples at a hospital in metropolitan Kampala (Uganda). Afr Health Sci. 2007;7(4):214-222. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3074367&tool=pmcentrez&rendertype=abstract.

Ksycki MF, Namias N. Nosocomial urinary tract infection. Surg Clin North Am. 2009;89(2):475-481, ix - x. http://www.ncbi.nlm.nih.gov/pubmed/19281895.

Erben N, Alpat SN, Kartal ED, Ozgüneş I, Usluer G. [Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents]. Mikrobiyol Bul. 2009;43(1):77-82. http://www.ncbi.nlm.nih.gov/pubmed/19334383.

Fink R, Gilmartin H, Richard A, Capezuti E, Boltz M, Wald H. Indwelling urinary catheter management and catheter-associated urinary tract infection prevention practices in Nurses Improving Care for Healthsystem Elders hospitals. Am J Infect Control. 2012;40(8):715-720.

http://www.ncbi.nlm.nih.gov/pubmed/22297241.

Parida S, Mishra SK. Urinary tract infections in the critical care unit: A brief review. Indian J Crit Care Med. 2013;17(6):370-374. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3902573&tool=pmcentrez&rendertype=abstract.

Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. Complicated catheterassociated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21(1):26-59. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2223845&tool=pmcentrez&rendertype=abstract.

Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009. International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625-663. doi:10.1086/650482.

Schaffer JN, Pearson MM. Proteus mirabilis and Urinary Tract Infections. Microbiol Spectr. 2015;3(5). http://www.ncbi.nlm.nih.gov/pubmed/26542036.

Burall LS, Harro JM, Li X, et al. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun. 2004;72(5):2922-2938. doi:10.1128/IAI.72.5.2922.

Mobley HL, Island MD, Massad G. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. Kidney Int Suppl. 1994;47:S129-S136. http://www.ncbi.nlm.nih.gov/pubmed/7869662.

Chenoweth CE, Gould C V, Saint S. Diagnosis, management, and prevention of catheter-associated urinary tract infections. Infect Dis Clin North Am. 2014;28(1):105-119.

http://www.ncbi.nlm.nih.gov/pubmed/24484578.

Chenoweth C, Saint S. Preventing catheter-associated urinary tract infections in the intensive care unit. Crit Care Clin. 2013;29(1):19-32. http://www.ncbi.nlm.nih.gov/pubmed/23182525.

Catheter-associated urinary tract infection in adults. http://www.uptodate.com/contents/catheter-associated-urinary-tract-infectioninadults?source=machineLearning&search=urinary+tract+infection&selectedTitle=3%7E150&sectionRank=1&anchor=H123172989#H123172989.

Pigrau C. [Nocosomial urinary tract infections]. Enferm Infecc Microbiol Clin. 2013;31(9):614-624. http://www.sciencedirect.com/science/article/pii/S0213005X12004375.

Downloads

Published

2021-08-23 — Updated on 2023-05-16

Issue

Section

ARTICLE OF SCIENTIFIC AND TECHNOLOGICAL RESEARCH

How to Cite

Nosocomial urinary infection and implicated microorganisms. (2023). Biociencias, 16(1). https://doi.org/10.18041/2390-0512/biociencias.1.7837